Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beardsley

Showing results (111-120 of 214) with videos related to

Pageof 22
Sort By:
European Journal of Pharmacology|April 20, 2010
The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapsePatrick M Beardsley, Keith L Shelton, Elizabeth Hendrick, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|October 1, 1995
Outcomes of a risk-reduction intervention with high-risk populations: the Harlem AIDS projectS Deren, W R Davis, M Beardsley, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|August 1, 1997
Gender differences and other factors associated with HIV testing in a national sample of active drug injectorsW R Davis, S Deren, M Beardsley, et al.
Australian and New Zealand Journal of Medicine|April 1, 1994
A comparison of hepatitis C virus (HCV)-RNA and--antibody as markers of infection and predictors of infectivityA M Beardsley, J T LaBrooy, L Rozen, et al.
Behavioural Pharmacology|March 29, 2001
The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administeredP M Beardsley, P Sokoloff, R L Balster, et al.
European Journal of Pharmacology|February 1, 2002
Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeysPatrick M Beardsley, Mario E Dance, Robert L Balster, et al.
Psychopharmacology|February 28, 2002
Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in miceCharles D Cook, Mario D Aceto, Andrew Coop, et al.
European Journal of Pharmacology|July 10, 2016
Oxycodone physical dependence and its oral self-administration in C57BL/6J miceRachel M Enga, Asti Jackson, M Imad Damaj, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 10, 2013
Grading of posterior staphyloma with spectral-domain optical coherence tomography and correlation with macular diseaseEhsan Rahimy, Robert M Beardsley, Jessica Gomez, et al.
Women & Health|June 26, 1998
Urban crack users: gender differences in drug use, HIV risk and health statusS Tortu, M Goldstein, S Deren, et al.
Pageof 22

Showing results (111-120 of 214) with videos related to

Sort By:
Pageof 22
European Journal of Pharmacology|April 20, 2010
The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapsePatrick M Beardsley, Keith L Shelton, Elizabeth Hendrick, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|October 1, 1995
Outcomes of a risk-reduction intervention with high-risk populations: the Harlem AIDS projectS Deren, W R Davis, M Beardsley, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|August 1, 1997
Gender differences and other factors associated with HIV testing in a national sample of active drug injectorsW R Davis, S Deren, M Beardsley, et al.
Australian and New Zealand Journal of Medicine|April 1, 1994
A comparison of hepatitis C virus (HCV)-RNA and--antibody as markers of infection and predictors of infectivityA M Beardsley, J T LaBrooy, L Rozen, et al.
Behavioural Pharmacology|March 29, 2001
The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administeredP M Beardsley, P Sokoloff, R L Balster, et al.
European Journal of Pharmacology|February 1, 2002
Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeysPatrick M Beardsley, Mario E Dance, Robert L Balster, et al.
Psychopharmacology|February 28, 2002
Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in miceCharles D Cook, Mario D Aceto, Andrew Coop, et al.
European Journal of Pharmacology|July 10, 2016
Oxycodone physical dependence and its oral self-administration in C57BL/6J miceRachel M Enga, Asti Jackson, M Imad Damaj, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 10, 2013
Grading of posterior staphyloma with spectral-domain optical coherence tomography and correlation with macular diseaseEhsan Rahimy, Robert M Beardsley, Jessica Gomez, et al.
Women & Health|June 26, 1998
Urban crack users: gender differences in drug use, HIV risk and health statusS Tortu, M Goldstein, S Deren, et al.
Pageof 22